Poll: Majority of U.S. voters approve of giving Medicare drug price negotiation authority
Fierce Healthcare
SEPTEMBER 29, 2021
Poll: Majority of U.S. voters approve of giving Medicare drug price negotiation authority. rking. Wed, 09/29/2021 - 15:53.
Sat.Sep 25, 2021 - Fri.Oct 01, 2021
145 
Amazon names 10 finalists in its first digital health accelerator
pharmaphorum
SEPTEMBER 29, 2021
Amazon’s push into healthcare takes many forms, and one is decidedly biotech-like – running an accelerator to identify and support startups with promising technology platforms. The online commerce giant’s first accelerator kicked off in June, focusing on digital health companies, and 427 applications from 31 countries around the world have now been winnowed down to 10 finalists.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Patients want to see more health industry collaboration: survey
Outsourcing Pharma
SEPTEMBER 30, 2021
A study by Charles River finds patients believe the overall quality of healthcare would increase if stakeholders across the life sciences collaborated more.
New report sheds light on medicine shortages in Northern Ireland following Brexit
Pharma Times
SEPTEMBER 28, 2021
Informa Pharma Intelligence (IPI) has found that some drug firms may withdraw up to 90% of their products from Northern Ireland, once the Brexit grace period has passed.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Amazon taps VR, voice assistant startups and 8 others for inaugural digital health accelerator
Fierce Healthcare
SEPTEMBER 28, 2021
Amazon taps VR, voice assistant startups and 8 others for inaugural digital health accelerator. hlandi. Tue, 09/28/2021 - 14:54.
Bayer teams up with Huma to apply AI to lung cancer diagnosis
pharmaphorum
SEPTEMBER 29, 2021
A research project between Bayer and digital health company Huma will use artificial intelligence to detect lung cancer in CT scans – and determine which type a patient has, in order to direct treatment. AI is already being applied by a number of groups, with some studies indicating it can even be more effective than trained radiologists in detecting subtle patterns that indicate the presence of tumours.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
I Holland Celebrates 75 Years of Excellence
Pharma Mirror
SEPTEMBER 30, 2021
As the longest established tablet compression tooling manufacturer in the world, I Holland is celebrating its 75th anniversary. The company has reached this remarkable milestone due to their commitment to research, development and investment which has established the company as the pre-eminent supplier of punches and dies to producers of tablets across the globe.
Right-wing physicians profit off of fake COVID-19 treatments, report finds
Fierce Healthcare
SEPTEMBER 30, 2021
Right-wing physicians profit off of fake COVID-19 treatments, report finds. agliadkovskaya. Thu, 09/30/2021 - 16:03.
Barts Health NHS Trust launches app for cognitively impaired
pharmaphorum
SEPTEMBER 28, 2021
An app to support people with cognitive disabilities, developed with clinicians at Barts Health NHS Trust, has started to be made available more widely to patients. The Hear Me Now app developed with UCLPartners and software company Maldaba is designed to improve quality of care for people with cognitive impairment, specifically adults with a learning disability.
COVID-19 treatment candidate headed to clinical trial in 2022
Outsourcing Pharma
SEPTEMBER 28, 2021
Q BioMed reports it expects candidate MAN-19, intended to treat COVID-19-related Acute Respiratory Distress Syndrome, to enter trials early next year.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
A*STAR and Local SME Work with Vaccination Centres to Deploy Automated Systems for Filling Syringes
Pharma Mirror
SEPTEMBER 30, 2021
SINGAPORE; The Agency for Science, Technology and Research (A*STAR) has developed an Automated Vaccine Inoculation Dispenser (AVID) system, which replaces the manual step of filling injection syringes with vaccine liquid. AVID is customised for the vaccination centres which are set up by the Ministry of Health and operated by private healthcare providers AVID was designed to address the labour-intensive steps of the vaccination process to reduce the workload of healthcare providers, increase acc
VR can help underserved patients, but reimbursement challenges stymie broader adoption, study finds
Fierce Healthcare
SEPTEMBER 30, 2021
VR can help underserved patients, but reimbursement challenges stymie broader adoption, study finds. hlandi. Thu, 09/30/2021 - 11:14.
Treatment for all: the key steps to better representation in pharma
pharmaphorum
SEPTEMBER 27, 2021
As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says pharma should reassess how it conducts clinical trials. The pharmaceutical industry is one of the most important industries in the world, providing lifesaving drugs and treatment to people who need it the most. This already significant industry is growing – it is estimated to be worth $1.27 trillion by end of 2020.
Pfizer kicks off trial for COVID-19 oral antiviral candidate
Outsourcing Pharma
SEPTEMBER 27, 2021
The protease inhibitor PF-07321332 (co-administered with ritonavir) is designed for patients exposed to (or showing the first signs of) the COVID-19 virus.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
John Lineen
Pharma Marketing Network
SEPTEMBER 29, 2021
John Lineen is a senior executive with strong marketing, digital, analytics, and CX experience in the pharmaceutical industry. John’s specialty is managing, launching, measuring, and optimizing large-scale digital and omnichannel programs. He uses his global corporate (9+ years at Bristol Myers Squibb, GlaxoSmithKline), digital agency (12+ years @ Digitas Health), consulting (McKinsey & Company), start-up, and engineering background to deliver engaging content and services that help HCPs and
Medicare Advantage premiums to decline slightly in 2022, Part D to rise by nearly 5%
Fierce Healthcare
SEPTEMBER 29, 2021
Medicare Advantage premiums to decline slightly in 2022, Part D to rise by nearly 5%. rking. Wed, 09/29/2021 - 14:49.
Top email calamities to avoid … and how to make an impact instead
pharmaphorum
SEPTEMBER 29, 2021
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. In this column he addresses the appropriate use of email and how to avoid nightmares in electronic communication. “My fiancée had bought me a string tanga birthday present.
CROs facing formidable challenges in clinical research: survey
Outsourcing Pharma
SEPTEMBER 28, 2021
Conducted by patient services specialist Greenphire, the survey checks in with contract research organizations and shows how they are approaching obstacles.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Timothy Glennon
Pharma Marketing Network
SEPTEMBER 29, 2021
Timothy Glennon . The post Timothy Glennon appeared first on Pharma Marketing Network.
CVS Caremark takes aim at health inequities, starting with sickle cell, HIV
Fierce Healthcare
SEPTEMBER 27, 2021
CVS Caremark takes aim at health inequities, starting with sickle cell, HIV. pminemyer. Mon, 09/27/2021 - 15:55.
Merck confirms $11.5bn Acceleron takeover deal
pharmaphorum
SEPTEMBER 30, 2021
After days of speculation, Merck & Co confirmed today that it has agreed to acquire Acceleron Pharma $1.5 billion, setting up what could be one of the largest biopharma acquisitions of 2021 so far. The $180-per-share deal – if completed – will give Merck a pair of blockbuster drug candidates, one of which is already on the market, and help to reduce its reliance on $14.4 billion immuno-oncology blockbuster Keytruda (pembrolizumab).
Merck: COVID-19 oral antiviral drug reduces risk of death
Outsourcing Pharma
OCTOBER 1, 2021
The pharma firm reports molnupiravir was shown to cut risk of hospitalization or death by 50% compared to placebos in a positive interim Phase III analysis.
Utrace Offers A Single Solution to Serialization Challenges
Pharma Mirror
SEPTEMBER 28, 2021
Unfair competition arising in the pharmaceutical markets and the presence of a shadow sector require the protection of the brand’s interests and confirmation of quality for the end customer. In recent years, the reaction to this has been the emergence of intercorporate methods of protecting goods from counterfeiting. The regulators of specific countries of national projects have started to control counterfeit and falsification by creating complex systems that verify each unit of goods.
Labor shortages in healthcare expected to rise as demand grows, report finds
Fierce Healthcare
SEPTEMBER 29, 2021
Labor shortages in healthcare expected to rise as demand grows, report finds. agliadkovskaya. Wed, 09/29/2021 - 16:45.
Sanofi abandons mRNA COVID jab, despite positive trial
pharmaphorum
SEPTEMBER 28, 2021
Sanofi has said that it won’t develop its mRNA-based vaccine for COVID-19 any further, even though it seemed to work in an early-stage trial, and will focus instead on another candidate partnered with GlaxoSmithKline. The French pharma group said it took the decision because mRNA vaccines from Pfizer/BioNTech and Moderna are already widely available today it will be too late to the market with its candidate, which was originated by its partner Translate Bio.
Mobile technology facilitates decentralized skin and wound trials
Outsourcing Pharma
SEPTEMBER 30, 2021
A leader from Swift Medical describes the companyâs skin and wound management technology, and how their tech empowers patient capture of vital information.
PMN Innovation Summit 2021
Pharma Marketing Network
SEPTEMBER 28, 2021
Name *. First. Last. Title * Company * Email *. Name This field is for validation purposes and should be left unchanged. The post PMN Innovation Summit 2021 appeared first on Pharma Marketing Network.
Humana launching 72 new Medicare plans for 2022
Fierce Healthcare
OCTOBER 1, 2021
Humana launching 72 new Medicare plans for 2022. pminemyer. Fri, 10/01/2021 - 11:09.
Key drug in Sanofi’s $1.45bn Kymab buyout shows promise in eczema
pharmaphorum
OCTOBER 1, 2021
Already a major player in atopic dermatitis with Dupixent, Sanofi looked to expand its position in the category earlier this year when it bought Kymab and its lead drug KY1005 for the skin disorder for $1.1 billion upfront. Now, it says the drug has delivered “exciting” results in a proof-of-concept trial. KY1005 – now renamed amlitelimab – is one of a handful of new drugs targeting OX40 ligand, an immune system regulator delivered by intravenous infusion once every 28 days.
Real-world data use in trials can yield real benefits: Firma
Outsourcing Pharma
SEPTEMBER 27, 2021
A leader from Firma Clinical Research advises that while using RWD can be daunting, putting the data to use can lead to a number of notable advantages.
Identifying the “Hero Items” that attract customers and drive supermarket sales
Fuld
SEPTEMBER 28, 2021
Background. Within the retail sector “hero items” or “destination items” are the standout products that attract customers to specific stores and drive additional sales, whether those are discretionary purchases or the weekly supermarket shop. The challenge for retailers is how to effectively measure performance to successfully identify these items, and what marketing strategy and tactics they should then apply to attract more customers and drive sales.
Providers cry foul over new surprise billing rule's arbitration process
Fierce Healthcare
OCTOBER 1, 2021
Providers cry foul over new surprise billing rule's arbitration process. rking. Fri, 10/01/2021 - 16:39.
Developing case-based content to engage HCPs
pharmaphorum
SEPTEMBER 30, 2021
In this instalment of EPG Health’s HCP engagement series, Georga Cottle discusses how case-based learning connects medical theory to medical practice. Medical education doesn’t stand still. The acute demands on today’s healthcare systems require ever-more effective learning opportunities for healthcare professionals (HCPs) and offer pharma companies valuable chances to support evidence-based clinical practice.
Let's personalize your content